. Author manuscript; available in PMC: 2020 Dec 1.

Published in final edited form as: Liver Transpl. 2019 Nov 4;25(12):1778–1789. doi: 10.1002/lt.25633

Table 4. Multivariate analysis for EAD in 458 primary LTs.

Pre-LT rifaximin < 28 days and longer CIT were identified independent risk factors for EAD.

Factors	Odds ratio	95% C.I. (lower-upper)	p value
Pre-LT rifaximin < 28 days	2.096	1.298–3.382	0.002
CIT (min)	1.003	1.002–1.005	<0.001
WIT (min)	1.012	0.998–1.027	0.096
Donor age (years)	1.016	0.995–1.038	0.135
Donor BMI (kg/m²)	1.029	0.991–1.069	0.136
DRI (point)	0.858	0.392–1.879	0.701